| Literature DB >> 30380827 |
Bob W J Pirok1,2, Dwight R Stoll3, Peter J Schoenmakers1.
Abstract
Entities:
Year: 2018 PMID: 30380827 PMCID: PMC6322149 DOI: 10.1021/acs.analchem.8b04841
Source DB: PubMed Journal: Anal Chem ISSN: 0003-2700 Impact factor: 6.986
Figure 1Examples of separations by 2D-LC. Top-left, HILIC × RPLC of polyphenols in apple extract;[6] top-middle, RPLC × RPLC of tryptic digest of three proteins;[14] top-right, HILIC × RPLC of polyether polyols;[9] bottom-left, HILIC × RPLC of therapeutic antibodies subunits;[15] bottom-middle, SAX × IP-RPLC of aged, synthetic dyes;[5] bottom-right, RPLC × RPLC of TCM Dengzhan Shengmai.[16] See respective papers for details. Top-left figure reproduced from Development of an improved online comprehensive hydrophilic interaction chromatography × reversed-phase ultrahigh-pressure liquid chromatography platform for complex multiclass polyphenolic sample analysis, Sommella, E.; Ismail, O. H.; Pagano, F.; Pepe, G.; Ostacolo, C.; Mazzoccanti, G.; Russo, M.; Novellino, E.; Gasparrini, F.; Campiglia, P. J. Sep. Sci., Vol. 40, Issue 10 (ref (6)). Copyright 2017 Wiley. Top-middle figure reprinted from J. Chromatogr. A, 1498, Sarrut, M.; Rouvière, F.; Heinisch, S., Theoretical and Experimental Comparison of One Dimensional versus Online Comprehensive Two Dimensional Liquid Chromatography for Optimized Sub-Hour Separations of Complex Peptide Samples, pp. 183–195 (ref (14)). Copyright (2017), with permission from Elsevier. Top-right figure reprinted from J. Chromatogr. A, 1569, Groeneveld, G.; Dunkle, M.N.; Rinken, M.; Gargano, A.F.G.; de Niet, A.; Pursch, M.; Mes, E.P.C.; Schoenmakers, P.J., Characterization of complex polyether polyols using comprehensive two-dimensional liquid chromatography hyphenated to high-resolution mass spectrometry, pp. 128–138 (ref (9)). Copyright (2018), with permission from Elsevier. Bottom-left figure reproduced from Stoll, D. R.; Harmes, D. C.; Staples, G. O.; Potter, O. G.; Dammann, C. T.; Guillarme, D.; Beck, A. Anal. Chem.2018, 90 (9), 5923–5929 (ref (15)). Copyright 2018 American Chemical Society. Bottom-middle figure reprinted from J. Chromatogr. A, 1436, Pirok, B. W. J.; Knip, J.; van Bommel, M. R.; Schoenmakers, P. J., Characterization of synthetic dyes by comprehensive two-dimensional liquid chromatography combining ion-exchange chromatography and fast ion-pair reversed-phase chromatography, pp. 141–146 (ref (5)). Copyright (2016), with permission from Elsevier. Bottom-right figure reprinted from J. Chromatogr. A, 1517, Sheng, N.; Zheng, H.; Xiao, Y.; Wang, Z.; Li, M.; Zhang, J., Chiral Separation and Chemical Profile of Dengzhan Shengmai by Integrating Comprehensive with Multiple Heart-Cutting Two-Dimensional Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry, pp. 97–107 (ref (16)). Copyright (2017), with permission from Elsevier.
SWOT Analysis of Heart-Cut Two-Dimensional Liquid Chromatography (LC-LC)
| strengths | weaknesses |
|---|---|
| • Very high resolving power | • Somewhat increased conceptual and instrumental complexity |
| • Added selectivity from second (“orthogonal”) dimension | • Analysis time is increased (especially when multiple fractions are selected for analysis in the second dimension) |
| • Choice from many different retention mechanisms | • Possibly reduced detection sensitivity |
| • Enhanced purification or purity assessment of target analytes | • Phase-system incompatibility issues |
| • Preparative separations possible | • Method development is relatively straightforward |
| • Greatly reduced uncertainty of peak assignments (in comparison with 1D-LC) | |
| • Readily combined with MS and MS/MS techniques |
These issues may (largely) be addressed by incorporating active-modulation techniques (see section Modulation below).
SWOT Analysis of Comprehensive Two-Dimensional Liquid Chromatography (LC × LC)
| strengths | weaknesses |
|---|---|
| • High peak capacities (1 000–10 000) routinely possible | • Added conceptual and instrumental complexity |
| • High peak-production rates (typically 1 peak per second) | • Rather long analysis times (typically 30 min–2 h) |
| • Choice from many different retention mechanisms | • Possibly reduced detection sensitivity |
| • Added selectivity from second (“orthogonal”) dimension | • Phase-system incompatibility issues |
| • Structured,
readily interpretable chromatograms | • Data-analysis software needed |
| • “Group-type” separations of classes of analytes | • Difficult and time-consuming method
development |
| • Readily combined with MS and MS/MS techniques | |
| • Greatly reduced uncertainty of peak assignments (in comparison with 1D-LC) |
In the case of low sample dimensionality.[22]
These issues may (largely) be addressed by incorporating active-modulation techniques (see section Modulation below).
This may be overcome by using advanced method-development software.
See Table for an overview of these.
IMS = ion-mobility spectrometry.
Overview of 2D-LC Applications from 2016 until October 2018a
| application | mode | 1D | 2D | detection | remarks | ref | ||
|---|---|---|---|---|---|---|---|---|
| Antibody-drug conjugates | N | - | P | SEC | RPLC | UV–vis | ( | |
| Antibody-drug conjugates | N | - | P | RPLC | RPLC | UV–vis | ( | |
| Antibody-drug conjugates | N | - | P | SEC | RPLC | UV–vis | ( | |
| Antibody-drug conjugates | N | - | P | HIC | RPLC | MS | ( | |
| Antibody-drug conjugates | N | × | P | RPLC | RPLC | MS, UV–vis | ( | |
| N | - | P | RPLC | RPLC | ||||
| Antibody-drug conjugates | N | × | P | HIC | RPLC | MS, UV–vis | ( | |
| Antibody-drug conjugates | N | × | P | HIC | SEC | MS | ( | |
| Antibody-drug conjugates (free species) | N | - | P | SEC | RPLC | UV–vis | ( | |
| Antibody-drug conjugate (free species) | N | - | P | MM | RPLC | MS | ( | |
| Biopharmaceuticals (impurities) | N | - | N | RPLC | RPLC | MS | ( | |
| Bovine insulin (degradants) | N | - | A | RPLC | RPLC | UV–vis | ( | |
| Monoclonal antibodies | N | - | P | Affinity | SEC | UV–vis | ( | |
| Monoclonal antibodies | N | - | P | WCX | SEC | UV–vis | mLC-LC | ( |
| Monoclonal antibodies | N | × | P | SCX | RPLC | MS | ( | |
| Monoclonal antibodies | N | - | P | SCX | RPLC | MS | ( | |
| Oligonucleotides (impurities) | N | - | S | SEC | IP-RPLC | MS | Utilized a 50 mm × 4.6 mm C18 trap. | ( |
| N | × | S | RPLC | IP-RPLC | ||||
| N | - | S | SAX | IP-RPLC | ||||
| N | × | S | IP-RPLC | IP-RPLC | ||||
| Therapeutic antibodies | N | - | P | IEX | RPLC | MS | ( | |
| Therapeutic antibodies | N | × | A | HILIC | RPLC | MS | ( | |
| AChE inhib. in wastewater effluent | N | × | P | RPLC | RPLC | MS, UV–vis | 2D effluent fractionated and studied. | ( |
| Emerging contaminants | N | × | P | RPLC | RPLC | MS | Column selection by orthogonality metrics. | ( |
| Polycyclic aromatics | N | × | P | RPLC | RPLC | UV–vis | Theoretical gradient optimization. | ( |
| Black chokeberries pomace | N | × | P | HILIC | RPLC | MS, UV–vis | ( | |
| Overripe fruits (carotenoids) | N | × | P | NPLC | RPLC | MS, UV–vis | ( | |
| Hop cones, pellet extracts | N | × | P | RPLC | RPLC | MS, UV–vis | ( | |
| N | × | P | HILIC | RPLC | ||||
| Soybean (Kunitz Trypsin Inhibitor) | F | - | M | WAX | SEC | MS | ( | |
| Corn oil (Triacylglycerols) | N | × | P | AgLC | RPLC | MS | Compared data-analysis techniques. | ( |
| Tea, Grape seed, red wine (extracts) | N | × | P | HILIC | RPLC | IMS-MS | Optimized LC × LC × IMS-MS separation. | ( |
| Wine (polyphenols and contaminants) | N | × | P | RPLC | RPLC | MS, UV–vis | ( | |
| Acyl-Coenzyme A (mouse liver) | N | - | P | RPLC | RPLC | MS | Two parallel 2D columns. | ( |
| Amino acids (of gramicidin, bacitracin) | N | × | P | Chiral | Chiral | UV–vis | Amino acids were derivatized. | ( |
| Amino acids (tea, amino acids) | F | - | M | RPLC | Chiral | UV–vis | ( | |
| Antioxidants ( | F | - | M | HILIC | RPLC | MS, UV–vis | ( | |
| Breast milk (fluoxetine, norfluoxetine) | N | - | P | SEC | Chiral | MS | ( | |
| N | - | P | SEC | RPLC | ||||
| Flavonoids | F | - | M | HILIC | RPLC | MS | ( | |
| Flavonoids | N | × | P | RPLC | RPLC | UV–vis | Microprep. to investigate recovery. | ( |
| Flavonoids from licorice | F | - | M | NPLC | RPLC | MS, UV–vis | Preparative scale. | ( |
| Furanocoumarins | N | × | P | RPLC | RPLC | UV–vis | Compared multivariate curve-resolution strategies in LC × LC. | ( |
| Lipidomics (brain tissue) | N | - | S | HILIC | RPLC | MS | ( | |
| Lipidomics (human plasma) | N | - | V | NPLC | RPLC | MS | ( | |
| Lipidomics (mice serum) | N | - | V | NPLC | RPLC | MS | ( | |
| Lipidomics (rat plasma) | F | - | M | MM | RPLC | MS | ( | |
| Lipidomics (cyanobacteria) | N | - | V | NPLC | RPLC | MS | ( | |
| Lipidomics (human plasma) | N | × | P | RPLC | HILIC | MS | Comparison with LC-TIMS-MS. | ( |
| Lipids (rice) | N | × | P | RPLC | HILIC | MS | ( | |
| Metabolites ( | N | × | P | RPLC | RPLC | MS, UV–vis | ( | |
| Metabolites (green cocoa beans) | N | × | S | HILIC | RPLC | MS, UV–vis | ( | |
| Metabolites (licorice) | N | × | P | HILIC | RPLC | MS, UV–vis | ZIC-HILIC | ( |
| Metabolites (microbial) | N | × | S | RPLC | RPLC | UV–vis | ( | |
| Metabolites ( | F | × | M | HILIC | RPLC | MS, UV–vis | ( | |
| Metabolites (rice plant) | N | × | P | HILIC | RPLC | MS | ( | |
| Metabolites (Vitamin D, human serum) | N | - | S | RPLC | RPLC | MS | PFP in 1D, C18 in 2D | ( |
| Metabolites and lipids (human plasma) | N | - | P | RPLC | RPLC | MS | Online prefractionation before 1D | ( |
| Metabolomics ( | N | × | P | RPLC | RPLC | MS, UV–vis | Multisegment shifting gradients. | ( |
| Phenolic acids | N | × | E | RPLC | RPLC | UV–vis | Evaporative membrane modulation. | ( |
| Phenolic acids and flavonoids | N | × | P | MM | RPLC | UV–vis | Simultaneous HILIC and RP in 1D | ( |
| Phenolic compounds (Grapevine canes) | N | × | P | HILIC | RPLC | MS, UV–vis | Compared a number of selectivities. | ( |
| Plant extracts and coffee | N | - | P | RPLC | RPLC | MS | Special concept of LC+LC. | ( |
| Polyphenols | N | × | S | HILIC | RPLC | MS | ( | |
| Polyphenols in red raspberry fruits shoots | N | × | P | RPLC | RPLC | MS | ( | |
| Procyanidins (cocoa) | N | × | P | HILIC | RPLC | UV–vis | Reported kinetic optimization tool. | ( |
| Proteinogenic amino acids | N | - | P | RPLC | Chiral | UV–vis | ( | |
| Pyrrolizidine alkaloids | N | - | P | RPLC | RPLC | MS | 1D at pH = 3, 2D at pH = 10 | ( |
| Steroids | N | × | P | TRLC | RPLC | UV–vis | TRLC as 1D facilitates 2D focusing. | ( |
| Testosterone (human serum) | N | - | P | RPLC | RPLC | MS | ( | |
| Urine (bovine) | N | × | S | RPLC | RPLC | MS | ( | |
| Urine (Steroids, Sulphonamides) | N | × | P | RPLC | RPLC | MS | CN, BEH and Phenyl studied for 1D | ( |
| Bioactives in plant extracts | N | × | S | RPLC | RPLC | ELSD | Fractionation system | ( |
| Heavy-oil fractions | N | × | P | NA-RPLC | NA-RPLC | CAD, UV–vis | CN, PFP and BiPh studied for 1D | ( |
| Household dust and dryer lint | N | × | P | RPLC | RPLC | MS | ( | |
| Lignin phenols | N | × | S | RPLC | SFC | UV–vis | ( | |
| Synthetic cannabinoids | N | × | P | RPLC | RPLC | MS | ( | |
| Synthetic dyes | N | × | P | SAX | IP-RPLC | UV–vis | ( | |
| Tobacco | N | - | S | SCX | RPLC | MS | ( | |
| Tobacco (snus) | N | - | P | RPLC | RPLC | MS | ( | |
| Vacuum-gas oil fraction | N | × | S | RPLC | RPLC | MS | Pulsed elution in 1D | ( |
| Phlorotannins in brown algae | N | × | P | HILIC | RPLC | MS, UV–vis | Use of Hansen solubility parameter to study extraction selectivity. | ( |
| Brown seaweed | N | × | P | HILIC | RPLC | MS, UV–vis | ( | |
| TCM (Additives) | N | - | S | Affinity | RPLC | UV–vis | ( | |
| TCM ( | F | - | M | RPLC | HILIC | MS, NMR | ( | |
| TCM ( | F | - | M | MM | MM | UV–vis | ( | |
| TCM ( | N | × | P | RPLC | RPLC | MS | ( | |
| TCM (Flos Carthami, dried flowers) | N | × | S | MM | RPLC | UV–vis | 1D: SEC-RPLC | ( |
| TCM ( | F | × | M | RPLC | HILIC | MS | ( | |
| TCM (Gegen-Qinlian Decoction) | N | × | P | RPLC | RPLC | MS | ( | |
| TCM (Notoginseng total saponins) | F | × | M | HILIC | RPLC | MS | ( | |
| TCM ( | F | - | M | RPLC | RPLC | UV–vis | Preparative scale | ( |
| TCM (Salvia miltiorrhiza) | F | × | M | HILIC | RPLC | MS | ( | |
| TCM (Salvia miltiorrhiza) | N | × | P | RPLC | RPLC | MS | ( | |
| TCM (sapinins and alkaloids) | F | - | M | RPLC | RPLC | MS | ( | |
| TCM (saponins in | N | × | P | RPLC | RPLC | MS | ( | |
| TCM ( | F | - | M | RPLC | HILIC | NMR,UV–vis | Preparative scale | ( |
| TCM (toad skin) | F | × | M | NPLC | RPLC | MS | ( | |
| TCM (Tropane alkaloids) | N | - | P | RPLC | SCX | UV–vis | ( | |
| TCM (Xuebijing) | N | - | P | RPLC | RPLC | MS, UV–vis | ( | |
| TCM (Zhibai Dihuang Granule) | F | × | M | SCX | RPLC | MS | ( | |
| TCM (Denzhan Shenmai) | N | × | P | RPLC | RPLC | MS | Integrated data from LC × LC with that from heart-cut 2D-LC. | ( |
| N | - | P | RPLC | Chiral | ||||
| TCM ( | N | - | P | HILIC | RPLC | UV–vis | ( | |
| TCM ( | F | × | P | HILIC | RPLC | MS | ( | |
| Peptide biomarkers (rat urine) | F | - | M | RPLC | RPLC | MS | ( | |
| Peptic digests | N | - | S | RPLC | MM | MS | ( | |
| Peptides | N | × | P | RPLC | RPLC | MS, UV–vis | ( | |
| Protein digests (plasma) | F | - | M | RPLC | RPLC | MS | ( | |
| Tryptic peptides | N | - | S | SCX | RPLC | MS | DCM instead of Gradient | ( |
| Tryptic peptides (Cortical neurons) | N | × | S | SCX | RPLC | MS | ( | |
| Tryptic peptides ( | N | - | S | RPLC | RPLC | MS | ( | |
| Tryptic peptides ( | F | - | M | RPLC | RPLC | MS | ( | |
| Tryptic peptides (human tissue, cancer) | N | - | P | RPLC | RPLC | MS | ( | |
| Tryptic peptides (mitochondrial proteins) | F | - | M | SCX | RPLC | MS | ( | |
| Tryptic peptides (lung adenocarcinoma) | F | - | M | SCX | RPLC | MS | ( | |
| Tryptic peptides ( | F | - | M | RPLC | RPLC | MS | ( | |
| Tryptic peptides ( | F | - | M | SCX | RPLC | MS | ( | |
| Tryptic peptides (serum) | F | - | M | SCX | RPLC | MS | ( | |
| Tryptic peptides (serum) | F | - | M | SCX | RPLC | MS | ( | |
| Peptides | N | × | P | RPLC | SEC | UV–vis | Studied stop-flow effects in 1D | ( |
| Peptides | N | - | P | Chiral | RPLC | FLD, MS | ( | |
| N | - | P | Chiral | Affinity | ||||
| Peptides | N | × | P | SEC | RPLC | UV–vis | 1D: Stop-flow; 1D dispersion studied. | ( |
| Peptides | N | - | P | RPLC | RPLC | MS, UV–vis | 2D-LC used as desalting tool. | ( |
| Antibiotic drug (cefonicid sodium) | N | - | P | RPLC | RPLC | MS | ( | |
| Antibiotic residues in dairy products | N | - | P | HILIC | RPLC | MS | ( | |
| Antibiotics | N | - | P | RPLC | RPLC | MS | ( | |
| Beta-blockers in human plasma | N | - | P | SEC | RPLC | FLD | RAM as 1D for prefractionation. | ( |
| Desonide cream | N | - | P | RPLC | RPLC | MS | Strong salt buffer in 1D | ( |
| Parental drug microdosing vehicle | N | - | P | RPLC | RPLC | MS, UV–vis | ( | |
| Pharmaceutical materials | N | - | P | RPLC | RPLC | MS, UV–vis | ( | |
| Pharmaceuticals | N | - | P | RPLC | SFC | UV–vis | sLC × SFC | ( |
| Pharmaceuticals | N | × | P | Chiral | Chiral | UV–vis | ( | |
| N | - | P | RPLC | Chiral | ||||
| Pharmaceuticals | N | - | S | RPLC | SFC | MS, UV–vis | ( | |
| Pharmaceuticals | N | × | P | RPLC | RPLC | MS, UV–vis | Applied theoretical optimization. | ( |
| Pharmaceuticals, Metabolites | N | - | S | RPLC | Chiral | MS | Chiral at SFC conditions. | ( |
| Therapeutic drug (in human plasma) | N | - | S | RPLC | RPLC | UV–vis | SCX as trapping column. | ( |
| Vidarabine monophosphate | N | - | S | RPLC | MM | MS | ( | |
| Vitamins | N | - | A | HILIC | RPLC | UV–vis | sLC × LC | ( |
| Oligomers (Oxidzed waxes) | N | × | P | NPLC | SEC | ELSD | 1D and 2D at high temperature. | ( |
| Polyether polyols | N | × | P | HILIC | RPLC | MS | ( | |
| Polymeric nanoparticles | N | × | S | HDC | SEC | UV–vis | ( | |
| Synthetic polymers (Polystyrene/Polybutadiene Block Copolymers) | N | × | S | NA-TGIC | SEC | UV–vis | ( | |
| N | × | S | RP-TGIC | LCCC | ||||
| Synthetic polymers (novolac) | N | × | A | SEC | RPLC | UV–vis | ( | |
| Synthetic polymers (branched poly (bisphenol A-carbonate)) | N | × | P | LCCC | SEC | LS, RID, UV–vis, VI | MALDI used off-line. LC × LC Correlated with Monte Carlo simulations. | ( |
| Synthetic polymers (HEUR) | N | × | P | SEC | RPLC | ELSD | ( | |
| Synthetic polymers (nonlinear) | N | × | P | NPLC | SEC | LS, RID, VI | ( | |
| Synthetic polymers (poloxamers) | N | × | P | LCCC | LCCC | ELSD | Use two 2D columns. | ( |
| Synthetic polymers (polystyrene) | N | × | P | NA-RPLC | SEC | UV–vis | 2D-col with longitudinal porosity gradient. | ( |
| Intact histone proteoforms | N | × | S | MM | RPLC | MS | Nanoflow LC × LC; 1D WCX-HILIC | ( |
| Intact proteins | N | × | P | SCX | RPLC | UV–vis | Application of multichannel detector[ | ( |
| Intact proteins and protein digests | N | × | P | SCX | IP-RPLC | MS, UV–vis | Photografted monolith for SCX. Optimized various parameters. | ( |
| Metaproteomics (soil) | N | - | S | SCX | RPLC | MS | ( | |
| Proteins in human plasma | N | × | S | SAX | RPLC | None | Array (8) of 2D columns, Fractionation | ( |
| Ethoxylate phosphate surfactants | N | × | S | HILIC | RPLC | UV–vis | ( | |
| Ionic surfactants | N | × | P | MM | RPLC | CAD | 1D: WCX-RPLC | ( |
| Nonionic surfactants in pharmaceuticals | N | × | P | HILIC | RPLC | ELSD, MS | ( | |
| Polymeric dispersants in detergents | N | - | P | SEC | RPLC | ELSD | ( | |
N = Online, F = Offline, × = Comprehensive, - = Heart-cut, P = Passive modulation (empty loops), A = Active-Solvent Modulation (ASM), E = Evaporation membrane, S = Active stationary-phase assisted modulation (SPAM), V = Vacuum-evaporation modulation (VEM), M = Manual/No modulation. CAD = charged-aerosol detection, ELSD = evaporative light-scattering detection, FLD = fluorescence detection, LS = light scattering, MS = mass spectrometry, RID = refractive-index detection, VI = viscometry. LS, RID, and VI are typically combined to obtain “triple detection”. See Modulation section for a detailed discussion of the different modulation techniques.
Figure 2Generic scheme of a loop-based, passive-modulation interface for use in 2D-LC. As the 1D effluent is sampled by one loop, the contents of the other loop are, without any further modification, injected into the second dimension. In the configuration shown, the loops are filled and emptied in opposite directions (“backflush” mode). The scheme shows an 8-port valve, but a 10-port valve can also be used.[26,27] In (multiple) heart-cut 2D-LC, the loops can be replaced by “decks” each containing an array of sampling loops to allow storage of more than one fraction.
Figure 3Illustration of the function of Active Solvent Modulation (ASM) for coupling the two dimensions of separation in a 2D-LC system. This valve has eight ports and four positions. Postions A and C are functionally identical to those of a conventional 8- or 10-port two position valve (e.g., see Figure ). In positions B and D, however, part of the flow from the 2D pump is split and travels through the bypass capillary. This portion of the flow joins the stream of fluid exiting the sample loop before the mixture leaves the valve and enters the 2D column. In this way, this split part of the 2D flow acts as a diluent for the 1D effluent fraction injected into the 2D column.
Figure 4Comparison of two 2D and 2D chromatograms for LC × LC separations of mAb fragments with (B) and without ASM (A). First dimension separations are in the HILIC mode with about 70% ACN in the eluting mobile phase for the peaks of interest, and 2D separations are in the RP mode with about 25% ACN in the starting mobile phase. In each case, 40 μL of 1D effluent is ultimately transferred to the 2D separation. In case B, the sample is diluted 1:2 with water-rich diluent, such that the total volume injected in each 2D cycle is 120 μL. The 2D chromatograms in panel C are extracted from the 2D chromatograms on the left at the position of the gray dashed line. Reproduced from Stoll, D. R.; Harmes, D. C.; Staples, G. O.; Potter, O. G.; Dammann, C. T.; Guillarme, D.; Beck, A. Anal. Chem.2018, 90 (9), 5923–5929 (ref[15]). Copyright 2018 American Chemical Society.
Figure 5Schematic of the two positions of a stationary-phase-assisted modulation (SPAM) interface. Rather than using large storage loops, analytes are effectively filtered out of the 1D effluent using low-volume trapping columns. Optionally, the 1D column effluent may be diluted using a weak eluent to facilitate retention on the traps. Moreover, the waste line may be equipped with a detector to monitor premature elution from the traps during method development. (Multiple) heart-cut 2D-LC setups are possible as long as the multiple traps are identical.
Figure 6RPLC × RPLC-MS separation of steroids in bovine urine using (A) passive modulation and (B) stationary-phase assisted modulation (SPAM). 76 analytes could be detected using SPAM due to the improvement in S/N, relative to 36 using passive modulation.[41] Reprinted from Anal. Chem. Acta, 1013, Baglai, A.; Blokland, M.H.; Mol, H.G.J.; Gargano, A.F.G.; van der Wal, Sj.; Schoenmakers, P.J., Enhancing detectability of anabolic-steroid residues in bovine urine by actively modulated online comprehensive two-dimensional liquid chromatography–high-resolution mass spectrometry, pp. 87–97 (ref (41)). Copyright (2018), with permission from Elsevier.
Figure 7Schematic of a vacuum-evaporation modulation (VEM) interface. 1D column effluent is thought to be rapidly evaporated due to the combination of supplied heat and applied vacuum, so that the analytes are deposited in the loop. Upon switching, the 2D eluent redissolves the analytes for introduction into the 2D column. Based on the work of ref (54).
Figure 8Illustration of four different modes of 2D-LC separation. For a more thorough explanation of the similarities and differences between these different modes of 2D separation see ref[61].
Figure 9HILIC × RP-LC × IMS-MS TIC separation of a phenolic extract of red wine. The chromatographic method was optimized using predictive Pareto optimization.[79] Reproduced from Venter, P.; Muller, M.; Vestner, J.; Stander, M.A.; Tredoux, A.G.J.; Pasch, H.; de Villiers, A. Anal. Chem.2018, 90, 11643–11650 (ref (80)). Copyright 2018 American Chemical Society.
Figure 10(A) Overview of applied retention mechanisms in the first (left) and second (right) dimensions. (B) Use of modulation strategies in noncomprehensive (left) and comprehensive (right) applications (see Modulation section for a technical clarification). (C) Overview of applied detection techniques. Note that one application may use more than one detection technique so that a pie chart is less appropriate in this case. Total number of applications: 161 (online noncomprehensive, 58; online comprehensive, 76; offline, 27. CAD = charged-aerosol detection, ELSD = evaporative light-scattering detection, FLD = fluorescence detection, LS = light scattering, MS = mass spectrometry, RID = refractive-index detection, VI = viscometry. Data covers all online applications from Table .
Figure 11Online 2D-LC separation of 2,4-dinitrobenzene (DNP) derivatives of all 20 proteinogenic amino acids (plus allo-threonine, allo-isoleucine, homoserine, ornithing, and β-alanine). The d-enantiomer always elutes after l-, except for glutamine and ornithine. The 1D separation is carried out in the RP mode and the 2D separation in the chiral mode. Figure based on ref (144) and kindly provided by M. Lämmerhofer.
Figure 12HILIC × RPLC-(+)HRMS separation of the castor oil ethoxylates. The 1D HILIC dimension (horizontal) indicates the degree of ethoxylation, while the 2D RPLC column (vertical) separates the ethoxylated species according to hydrophobicity. Various ethoxylated fatty acids as well as glycerol ethoxylated mono-, di-, tri-, tetra-, and penta-esters were identified using the obtained accurate mass and isotope distributions. Reprinted from J. Chromatogr. A, 1569, Groeneveld, G.; Dunkle, M.N.; Rinken, M.; Gargano, A.F.G.; de Niet, A.; Pursch, M.; Mes, E.P.C.; Schoenmakers, P.J., Characterization of complex polyether polyols using comprehensive two-dimensional liquid chromatography hyphenated to high-resolution mass spectrometry, pp. 128–138 (ref (9)). Copyright (2018), with permission from Elsevier.